Target intelligence / Profile preview

RNA, U6 small nuclear 204, pseudogene (RNU6-204P)

Target
RNU6-204P
Molecular classification
Other, Pseudogene, Small nuclear RNA pseudogene, Noncoding RNA pseudogene
01

Overview

RNA, U6 small nuclear 204, pseudogene (RNU6-204P) is a classified pseudogene of the U6 small nuclear RNA (snRNA) gene family[5]. U6 snRNA is a critical component of the spliceosome complex responsible for excising introns from pre-mRNA during RNA splicing, but pseudogenes like RNU6-204P do not encode a functional product[1][3][5]. Pseudogenes arise from duplication or retrotransposition events and are generally non-functional due to mutations or truncations that disrupt the original gene's ability to produce a working RNA or protein[2][5]. Although historically considered genomic "junk," some pseudogenes can have regulatory influence on gene expression—such as acting as decoys for microRNAs or producing regulatory noncoding RNAs in specific contexts[2]. However, there is currently no evidence that RNU6-204P acts as a therapeutic target, biomarker, or has any safety concerns or disease links. It is classified as a noncoding RNA pseudogene and maintains relevance mainly as a genomic feature rather than a functional biological or therapeutic agent[5].

Other names
RNU6-204P
02

Biological functions

Other (no direct function; see description)
03

Disease associations

Other (no direct disease role; see description)

Beyond the preview

Go deeper on RNA, U6 small nuclear 204, pseudogene (RNU6-204P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 204, pseudogene (RNU6-204P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call